Intrinsic Value of S&P & Nasdaq Contact Us

Pharvaris N.V. PHVS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • NL • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$45.60
+59%

Pharvaris N.V. (PHVS) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 10 Buy, 1 Hold.

The consensus price target is $45.60 (low: $38.00, high: $60.00), representing an upside of 59% from the current price $28.68.

Analysts estimate Earnings Per Share (EPS) of $-2.72 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.48 vs est $-2.72 (beat +8.7%). Analyst accuracy: 90%.

PHVS Stock — 12-Month Price Forecast

$45.60
▲ +59.00% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Pharvaris N.V., the average price target is $45.60, with a high forecast of $60.00, and a low forecast of $38.00.
The average price target represents a +59.00% change from the last price of $28.68.
Highest Price Target
$60.00
Average Price Target
$45.60
Lowest Price Target
$38.00

PHVS Analyst Ratings

Buy
11
Ratings
10 Buy
1 Hold
Based on 11 analysts giving stock ratings to Pharvaris N.V. in the past 3 months
Rating breakdown
Buy
10 91%
Hold
1 9%
91%
Buy
10 analysts
9%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — PHVS

90%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual –$2.48 vs Est –$2.72 ▲ 9.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — PHVS

Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message